Xinjiang Tianye Water Saving Irrigation System Company Limited - 0840.HK

0840.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
0840.HK	0.5	0.5	-0.9	-4.5	10.5	22.1	-15.7	-40.8	-70	-86.5
S&P 500	1.0	0.6	1.1	2.4	8.9	23.6	36.4	80.6	195.1	33856.2

Compare 0840.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	0840.HK
name	Xinjiang Tianye Water Saving Irrigation System Company Limited
price	0.21
changes percentage	0.4785
change	0.001
day low	0.207
day high	0.21
year high	0.228
year low	0.123
market cap	108580008
price avg 50	0.21496
price avg 200	0.186275
exchange	HKSE
volume	400000
avg volume	6322
open	0.207
previous close	0.209
eps	-0.02
pe	-10.5
earnings announcement	2025-03-26T10:59:00.000+0000
shares outstanding	517047657
timestamp	2025-01-17 06:13:40

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Quarterly Financial Health: 33.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	2219335910	1439367415	54.19
gross profit	100866950	16667288	505.18
gross profit ratio	0.05	0.01	292.49
research and development expenses	18542624	6762506	174.20
operating expenses	103049119	65136692	58.20
interest income	1629856	589123	176.66
interest expense	3309026	2994011	10.52
ebitda	19070194	-57129313.35	133.38
ebitdaratio	0.01	-0.02	149.51
operating income	-2182169.57	-48469404.11	95.50
operating income ratio	-0.0	-0.03	97.08
net income	-11554963.31	-81410081.48	85.81
net income ratio	-0.01	-0.06	90.79
eps	-0.02	-0.16	86.12

Overall Score of Annual Income Statement

None

Detailed Analysis

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	508710500	508710500	0.0
gross profit	29298500	29298500	0.0
gross profit ratio	0.06	0.06	0.0
research and development expenses	1369000	1369000	0.0
operating expenses	20066000	20066000	0.0
interest income	0	0	NaN
interest expense	0	0	NaN
ebitda	16575000	16575000	0.0
ebitdaratio	0.03	0.03	0.0
operating income	9232500	9232500	0.0
operating income ratio	0.02	0.02	0.0
net income	8243499	8243499	0.0
net income ratio	0.02	0.02	0.0
eps	0.02	0.02	0.0

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	1219949729	1029410167	18.51
total liabilities	769279416	582612940	32.04
total equity	450670301	446797227	0.87
cash and cash equivalents	340794909	238746479	42.74
short term investments	0	0	NaN
long term investments	711959	1315145	-45.86
total current assets	997561565	794589894	25.54
total non current assets	222388163	234820273	-5.29
total current liabilities	719357536	525146058	36.98
total non current liabilities	49921880	57466881	-13.13
common stock	519521560	519521560	0.00
retained earnings	-126258689	-154691412.75	18.38
total debt	118898302	130348021	-8.78

Overall Score of Annual Balance Sheet

None

Detailed Analysis

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	1417829000	1417829000	0.00
total liabilities	948057000	948057000	0.00
total equity	469772000	469772000	0.00
cash and cash equivalents	417649000	417649000	0.00
short term investments	0	0	NaN
long term investments	712000	712000	0.00
total current assets	1190986000	1190986000	0.00
total non current assets	226843000	226843000	0.00
total current liabilities	833284000	833284000	0.00
total non current liabilities	114773000	114773000	0.00
common stock	519522000	519522000	0.00
retained earnings	-107855000	-107855000	0.00
total debt	155524000	103978000	49.57

Overall Score of Quarterly Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Debt: Total Debt increased to 156 million in 2024Q2 from 104 million in 2024Q1 representing a change of 49.57%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	98103949	92106555	6.51
operating cash flow	129659425	60298373	115.03
free cash flow	115139471	53727808	114.30
capital expenditure	-14519954	-6570564.35	-120.98
depreciation and amortization	19086406	19789970	-3.56
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	0	14479371	-100.00
inventory	78157257	-1681195.05	4748.91
acquisitions net	0	0	NaN
investments in property plant and equipment	-14519954	-6570564.35	-120.98
net cash used for investing activites	12932286	-6547467.01	297.52
debt repayment	-15110000	45636640	-133.11
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-10284074	-14793116	30.48
net cash used provided by financing activities	-44487763	38355648	-215.99
cash at end of period	334353299	236223587	41.54
accounts receivables	-154923852	-14479371	-969.96
cash at beginning of period	236249350	144117032	63.93

Overall Score of Annual Cashflow Statement

None

Detailed Analysis

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	37032000	37032000	0.0
free cash flow	37032000	37032000	0.0
capital expenditure	0	0	NaN
depreciation and amortization	6648500	6648500	0.0
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	0	0	NaN
net cash used for investing activites	-10398500	-10398500	0.0
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	11793500	11793500	0.0
net change in cash	38427000	38427000	0.0
cash at end of period	38427000	38427000	0.0
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	4.27	2.77	54.18
net income per share	-0.02	-0.16	85.81
operating cash flow per share	0.25	0.12	115.02
free cash flow per share	0.22	0.1	114.30
cash per share	0.66	0.46	42.74
book value per share	0.87	0.86	0.86
tangible book value per share	0.75	0.73	3.05
shareholders equity per share	0.8	0.82	-2.27
interest debt per share	0.24	0.26	-8.35
market cap	84264223.28	74774218.61	12.69
enterprise value	-137632383.72	-33624239.39	-309.32
pe ratio	-7.29	-0.92	-693.96
price to sales ratio	0.04	0.05	-26.91
pocfratio	0.65	1.24	-47.59
pfcf ratio	0.73	1.39	-47.41
pb ratio	0.2	0.18	15.31
ptb ratio	0.2	0.18	15.31
ev to sales	-0.06	-0.02	-165.47
enterprise value over ebitda	-7.22	0.59	-1326.23
ev to operating cash flow	-1.06	-0.56	-90.36
ev to free cash flow	-1.2	-0.63	-91.00
earnings yield	-0.14	-1.09	87.40
free cash flow yield	1.37	0.72	90.17
debt to equity	0.29	0.31	-6.67
debt to assets	0.1	0.13	-23.03
net debt to ebitda	-11.64	1.9	-713.24
current ratio	1.39	1.51	-8.35
interest coverage	-0.66	-16.19	95.93
income quality	-12.39	-0.74	-1573.09
dividend yield	0.12	0.2	-38.31
payout ratio	-0.89	-0.18	-389.80
sales general and administrative to revenue	0.01	0.01	-14.26
research and ddevelopement to revenue	0.01	0.0	77.83
intangibles to total assets	0.05	0.07	-25.32
capex to operating cash flow	0.11	0.11	2.77
capex to revenue	0.01	0.0	43.32
capex to depreciation	0.76	0.33	129.13
stock based compensation to revenue	0	0	NaN
graham number	0.63	1.7	-62.76
roic	-0.01	-0.08	85.57
return on tangible assets	-0.01	-0.08	88.23
graham net net	-0.1	-0.1	-0.40
working capital	278204029	269443836	3.25
tangible asset value	391209353	379612791	3.05
net current asset value	228282149	211976954	7.69
invested capital	456430821	461428650	-1.08
average receivables	243442670	157252386.5	54.81
average payables	387473326	251068029.5	54.33
average inventory	299767089.5	352029815	-14.85
days sales outstanding	53.86	40.42	33.23
days payables outstanding	75.24	86.78	-13.30
days of inventory on hand	44.47	87.59	-49.22
receivables turnover	6.78	9.03	-24.94
payables turnover	4.85	4.21	15.34
inventory turnover	8.21	4.17	96.94
roe	-0.03	-0.19	85.48
capex per share	0.03	0.01	120.98

• Negative

  ROE: Return on Equity (ROE) increased to -0.03 on 2023-12-31 from -0.19 on 2022-12-31, representing a change of 85.48%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -7.29 on 2023-12-31 from -0.92 on 2022-12-31, representing a change of -693.96%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.39 on 2023-12-31 from 1.51 on 2022-12-31, representing a change of -8.35%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.29 on 2023-12-31 from 0.31 on 2022-12-31, representing a change of -6.67%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
0840.HK
calendar year	2024	2024	NaN
revenue per share	0.98	0.98	0.00
net income per share	0.02	0.02	0.00
operating cash flow per share	0.07	0.07	0.00
free cash flow per share	0.07	0.07	0.00
cash per share	0.8	0.8	0.00
book value per share	0.9	0.9	0.00
tangible book value per share	0.87	0.87	0.00
shareholders equity per share	0.84	0.84	0.00
interest debt per share	0.3	0.2	49.57
market cap	86505980.59	68617790.41	26.07
enterprise value	-175619019.41	-245053209.59	28.33
pe ratio	2.62	2.08	26.07
price to sales ratio	0.17	0.13	26.07
pocfratio	2.34	1.85	26.07
pfcf ratio	2.34	1.85	26.07
pb ratio	0.2	0.16	26.07
ptb ratio	0.2	0.16	26.07
ev to sales	-0.35	-0.48	28.33
enterprise value over ebitda	-10.6	-14.78	28.33
ev to operating cash flow	-4.74	-6.62	28.33
ev to free cash flow	-4.74	-6.62	28.33
earnings yield	0.1	0.12	-20.68
free cash flow yield	0.43	0.54	-20.68
debt to equity	0.36	0.24	49.57
debt to assets	0.11	0.07	49.57
net debt to ebitda	-15.81	-18.92	16.43
current ratio	1.43	1.43	0.00
interest coverage	0	0	NaN
income quality	4.49	4.49	0.00
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0.03	0.03	0.00
research and ddevelopement to revenue	0.0	0.0	0.00
intangibles to total assets	0.01	0.01	0.00
capex to operating cash flow	0	0	NaN
capex to revenue	0	0	NaN
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	0.55	0.55	0.00
roic	0.01	0.01	0.00
return on tangible assets	0.01	0.01	0.00
graham net net	-0.32	-0.32	0.00
working capital	357702000	357702000	0.00
tangible asset value	452652000	452652000	0.00
net current asset value	242929000	242929000	0.00
invested capital	570148000	570148000	0.00
average receivables	241062000	284266449.5	-15.20
average payables	488094000	462394289.5	5.56
average inventory	368336000	313232758.5	17.59
days sales outstanding	42.65	42.65	0.00
days payables outstanding	91.63	91.63	0.00
days of inventory on hand	69.15	69.15	0.00
receivables turnover	2.11	2.11	0.00
payables turnover	0.98	0.98	0.00
inventory turnover	1.3	1.3	0.00
roe	0.02	0.02	0.00
capex per share	0	0	NaN

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-06-30 Q2 from 0.02 on 2024-03-31 Q1, representing a change of 0.00%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 2.62 on 2024-06-30 Q2 from 2.08 on 2024-03-31 Q1, representing a change of 26.07%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.43 on 2024-06-30 Q2 from 1.43 on 2024-03-31 Q1, representing a change of 0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.36 on 2024-06-30 Q2 from 0.24 on 2024-03-31 Q1, representing a change of 49.57%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None